Li Wenlong, Sun Honghao, Xu Shengtao, Zhu Zheying, Xu Jinyi
State Key Laboratory of Natural Medicines & Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, PR China.
Division of Molecular Therapeutics & Formulation, School of Pharmacy, The University of Nottingham, University Park Campus, Nottingham NG7 2RD, UK.
Future Med Chem. 2017 Oct;9(15):1765-1794. doi: 10.4155/fmc-2017-0100. Epub 2017 Sep 20.
The vital roles of microtubule in mitosis and cell division make it an attractive target for antitumor therapy. Colchicine binding site of tubulin is one of the most important pockets that have been focused on to design tubulin-destabilizing agents. Over the past few years, a large number of colchicine binding site inhibitors (CBSIs) have been developed inspired by natural products or synthetic origins, and many moieties frequently used in these CBSIs are structurally in common. In this review, we will classify the CBSIs into classical CBSIs and nonclassical CBSIs according to their spatial conformations and binding modes with tubulin, and highlight the privileged structures from these CBSIs in the development of tubulin inhibitors targeting the colchicine binding site.
微管在有丝分裂和细胞分裂中的重要作用使其成为抗肿瘤治疗的一个有吸引力的靶点。微管蛋白的秋水仙碱结合位点是设计微管蛋白去稳定化剂时最为关注的重要口袋之一。在过去几年里,受天然产物或合成来源的启发,已经开发出了大量的秋水仙碱结合位点抑制剂(CBSIs),并且这些CBSIs中经常使用的许多基团在结构上具有共性。在本综述中,我们将根据CBSIs与微管蛋白的空间构象和结合模式将其分为经典CBSIs和非经典CBSIs,并着重介绍这些CBSIs中在开发靶向秋水仙碱结合位点的微管蛋白抑制剂过程中的优势结构。